CURRICULUM VITAE
Mary Ellen Csuka MD
Mary Ellen Csuka MD
Professor
Department of Medicine
Division of Rheumatology
Department of Medicine
Division of Rheumatology
OFFICE ADDRESS: |
The Hub for Collaborative Medicine |
8701 Watertown Plank Road |
Milwaukee, WI 53226 |
EDUCATION: |
09/1968 - 06/1972 B.S., Fordham University, Bronx, NY |
06/1974 - 06/1977 M.D., New York Medical College, Valhalla, NY |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
01/1977 - 06/1980 Resident, Department of Internal Medicine, The Hartford Hospital, Hartford, Connecticut 06115 |
1982 - 1985 Clinical Rheumatology Assistant to Dr. Daniel McCarty, Professor & Chairman, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226 |
09/1985 - 08/1986 Rheumatology Registrars to Professor Dame Carol M Black, FMedSci, West Middlesex University, West Middlesex University Hospital, Isleworth, Middlesex TW7 6AF |
2005 - 2006 University of Wisconsin-Milwaukee, Faculty Leadership Development Program, UW-Medical College of Wisconsin, Certificate of Completion, Milwaukee, WI |
FACULTY APPOINTMENTS: |
07/1980 - 06/1982 Instructor of Medicine, Department of Medicine, Division of General Internal Medicine, Medical College of Wisconsin, Milwaukee, WI 53226 |
07/1982 - 06/1987 Assistant Professor, Department of Medicine, Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI 53226 |
07/1987 - 06/2006 Associate Professor, Department of Medicine, Division of Rheumatology, The Medical College of Wisconsin, Milwaukee, WI 53226 |
07/2006 - Present Professor, Department of Medicine, Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI 53226 |
ADMINISTRATIVE APPOINTMENTS: |
1999 - Present Director, Rheumatology Inpatient Consultative, Medical College of Wisconsin, Milwaukee, WI |
2001 - 2012 Founder and Director, Osteoporosis Clinic, Medical College of Wisconsin, Milwaukee, WI |
2001 - 2005 Director, Rheumatology Clinic, Medical College of Wisconsin, Milwaukee, WI |
2003 - Present Scleroderma Clinic, Scleroderma Foundation Research and Treatment Center, Froedtert and Medical College Clinics, 9200 W. Wisconsin Avenue, Milwaukee, WI 53226 |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
2004 - 2012 Epic Physician Council, Froedtert and Medical College Clinics, 9200 W. Wisconsin Ave., Milwaukee, WI 53226 |
HOSPITAL STAFF PRIVILEGES: |
1979 - 1980 Emergency Room Physician, Emergency Room, Winsted Hospital, Winsted, CT 06098 |
1980 - 1996 Milwaukee County Medical Complex, 8700 W. Wisconsin Avenue, Milwaukee, WI 53226 |
1982 - Present Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Avenue, Milwaukee, WI 53226 |
1988 - 2012 Zablocki Veterans Administration Medical Center, 5000 W. National Avenue, Milwaukee, WI 53295 |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
National Board of Medical Examiners | 1977 | None |
American Board of Internal Medicine | 09/1980 | None |
ABIM - Rheumatology | 11/1996 | None |
ABIM - Geriatric Medicine | 2009 | 2019 |
Certificates | Issued By | Issue Date | Expiration |
ACLS | AHA | 1980 | None |
Rodnan Skin Score | SCOT | 05/13/2005 | None |
Certified Clinical Densitometrist (CCD) | ISCD | 07/29/2019 | 07/29/2024 |
CITI Refresher | MCW - CITI program | 05/27/2020 | 05/27/2023 |
Basic CITI | CITI program | 05/27/2020 | 05/27/2023 |
Human Research - Biomedical Research and Good Clinical Practices | MCW - CITI Program | 05/28/2023 | 05/28/2026 |
Good Clinical Practice Course (US FDA focus) 2-GCP | MCW - CITI Program | 08/17/2024 | 08/17/2027 |
Human Research - Learner Group 3 - 4 Refresher Course | MCW - CITI Program | 08/17/2024 | 08/17/2027 |
Licensure | Number | Issue Date | Expiration |
DEA | AC9388009 | 08/1978 | 08/31/2024 |
Wisconsin License | 23008 | 07/11/1980 | 10/31/2025 |
AWARDS AND HONORS: |
05/1972 - Present Magna Cum Laude, Kappa Gamma Pi |
05/1973 - Present Phi Beta Kappa |
1977 - Present Alpha Omega Alpha |
1985 - Present Certification of Leadership Award - YWCA of Greater Milwaukee |
1992 - Present Who's Who Registry of Rising Young Americans |
1996 - Present Best Doctors in America®, Category; Rheumatology (elected by peers) |
1998 - Present AMA Physician's Recognition Award |
2004 - 2008 2010, 2014 - 2016 "Milwaukee's Top Doctors, " Category; Rheumatology, Milwaukee Magazine (elected by peers) |
2004 - Present United Who's Who |
2012 - Present Best Doctors in America®, Category; Geriatric Medicine (elected by peers) |
07/20/2024 Doctor of the Year, National Scleroderma Foundation |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
Alpha Omega Alpha Medical Honor Society |
American Association for the Advancement of Science |
American College of Physicians (Fellow) |
American College of Rheumatology (Fellow) |
American Federation for Clinical Research |
Scleroderma Clinical Trials Consortium |
International Society for Clinical Densitometry |
Society of Irish and American Rheumatologist |
Wisconsin Bone Club |
Pulmonary Hypertension Association Clinician and Researcher |
International Bone and Mineral Society |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
10/2003 - 10/2006 Treasurer, ACR/ARHP Annual Meeting, Scleroderma Clinical Trials Consortium, Title: Moderator, Systemic Sclerosis, Fibrosing Syndromes and Raynaud’s-Clinical Aspects and Therapeutics, III |
08/2012 - 06/2020 Chairperson, Protocol: FHCRC 2533 – A Phase II Multi-Center Study of High-Dose Cyclophosphamide
and Antithymocyte Globulin Followed by Autologous Hematopoietic Cell Transplantation
with Post Transplant Maintenance for the Treatment of Systemic Sclerosis. Short Title:
Scleroderma Treatment with Autologous Transplant (STAT) Study, Data and Safety Monitoring Board (DSMB) |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
International |
Update on Fibromyalgia, Royal Free Hospital, London, U.K., 07/1996 |
Regional |
Rheumatologic Diagnosis, Intensive Training Program for the Wisconsin Geriatric Education Center, Chippewa Falls, WI, 06/03/1998 |
Cox –2 Sparing Drugs and Treatment of Arthritis, Annual Staff Meeting, Northwest General Hospital, Milwaukee, WI, 06/1999 |
Osteoporosis, Women’s Health for Primary Care Physicians, Medical College of Wisconsin OB-GYN, Milwaukee, WI, 08/10/1999 |
New Therapies for Rheumatoid Arthritis: Role of TNFa Antagonists, 12th Annual MCW Primary Care Conference, Egg Harbor, WI, 10/09/1999 |
Cox-2 Specific Inhibitors in the Treatment of Arthritis, Family Practice Clinical Conference, St. Francis Hospital, Milwaukee, WI, 11/10/1999 |
Osteoporosis 2000: Who, When & How to Treat,, Symposium Planning Committee, Wyndham Milwaukee Center Hotel, Milwaukee, WI, 11/18/2000 |
Painting a Brighter Picture for PAH Patients, PAH Symposium - Panel Discussant, Milwaukee, WI, 04/2002 |
Rheumatology and Pharmacology: Conservative Management of the RA Patient, Invited lectures for Current Trends for Treatment of The Arthritic Upper Extremity presented by The University of Wisconsin-Milwaukee, College of Health Sciences and the American Society of Hand Therapists, 04/11/2003 |
Understanding Other Forms of Arthritis and Related Conditions, Invited lectures for Current Trends for Treatment of The Arthritic Upper Extremity presented by The University of Wisconsin-Milwaukee, College of Health Sciences and the American Society of Hand Therapists, Milwaukee, WI, 04/11/2003 |
Duration and Safety of Immunomodulator Therapy in IBD: A Rheumatologist's Perspective, Presented at Difficult Decisions in IBD sponsored by CCFA Wisconsin Chapter, Wisconsin Dells, WI, WI, 03/27/2004 |
Physical Therapy and Occupational Therapy in Osteoporosis, Wisconsin's Osteoporosis Symposium, Milwaukee, WI, 06/25/2004 |
Pulmonary Hypertension and Connective Tissue Disease: Shedding Light on Pulmonary Arterial Hypertension, Sponsored by the Pulmonary Hypertension Association, Chicago, IL, 10/08/2005 |
Osteoporosis in Rheumatologic Practice, The Pfister Hotel Wisconsin Osteoporosis Symposium, Milwaukee, WI, 06/16/2006 |
Clinical Densitometry and Osteoporosis, 2007 Annual Spring Meeting, Transitioning from Nuclear Medicine to Molecular Imaging: Are We Really Ready? Central Chapter Society of Nuclear Medicine, Chicago, IL, 03/10/2007 |
Scleroderma 101: Understanding the Basics of Systemic Sclerosis, Rheumatology Nurses' Society 2024 Winter Symposium, Virtual, 01/11/2025 |
Scleroderma, 2025 Wisconsin Rheumatology Association Annual Meeting, Kohler, WI, 03/21/2025 |
"Medical Management of Rheumatoid Arthritis of the Cervical Spine, " 10th Annual MCW Spine Symposium, Children's Hospital, Milwaukee |
Local |
Antibodies and Scleroderma, Scleroderma Lunch & Learn Webinar, West Allis-West Milwaukee Recreation Department- 2450 S. 68th Street - West Allis, WI 53219, 03/29/2025 |
COMMITTEE SERVICE: |
Medical College of Wisconsin |
1982 - 1985 The Impaired Residents Committee, Medical College Affiliated Hospitals Program, Medical College of Wisconsin |
1984 - 1985 Ad Hoc Committee, Departmental Annual Report, Medical College of Wisconsin |
1986 - 1989 House Staff Assistance Committee, Medical College Affiliated Hospitals Program, Medical College of Wisconsin |
1991 - 1992 Dean's Task Force on PM&R, Medical College of Wisconsin |
2001 - 2002 Academic Standing Committee (elected by peers), Medical College of Wisconsin |
2002 - 2009 Review Committee, Sabbatical Leave and Faculty Vitality Awards, Medical College of Wisconsin |
Hospital |
1987 - 1998 Joint Credentials Committee, Froedtert Memorial Lutheran Hospital/Milwaukee County Medical Complex, Milwaukee, WI |
1992 - 1993 Patient Education Committees, Froedtert Memorial Lutheran Hospital |
MCW TEACHING ACTIVITIES: |
Medical Student Education |
1981 - 1982 Sophomore Preceptor, Introduction to Clinical Medicine |
1982 - 1987 Instructor, Junior Rounds |
1991 “Inflammation and Biochemistry”, Clinical Correlation Lecture,
Department of Biochemistry
|
1995 Physical Diagnosis |
09/2013 2 Sessions; Pathologic History & Exam Findings,
Musculoskeletal Skills Workshop for Bench-to-Bedside
|
04/03/2014 Discussant, Clinical Pathologic Conference |
09/2015 Musculoskeletal Skills Workshop for Bench-to-Bedside
2 Sessions; Pathologic History & Exam Findings
|
09/2016 Musculoskeletal Skills Workshop for Bench-to-Bedside
2 Sessions; Pathologic History & Exam Findings
|
Resident and Fellow Education |
1989 Arthritis of the Foot, Ortho-Rheum Conference |
01/1992 Helpful Laboratory Tests in Rheumatology, Ortho-Rheum
Conference
|
09/1992 "Osteoporosis, " Ortho-Rheum Conference, Children's Hospital |
11/1992 Geriatric Rheumatology Core Curriculum lecture |
12/1992 Neurologic complications of Rheumatic Diseases, Department of Neurology |
10/1995 “Avascular necrosis,” Rheum Conference |
08/1998 "NSAIDS, " Ortho-Rheum Conference |
11/1998 "Rheumatoid Arthritis, " Internal Medicine Resident Lecture, FMLH/VAMC |
05/1999 "Osteoporosis, " Ortho-Rheum Conference, Children's Hospital |
06/1999 "Cox -2 Sparing Drugs and Treatment of Arthritis, " Family Practice |
12/02/1999 "Update on Scleroderma, " Internal Medicine Resident Lecture, FMLH/VAMC |
12/16/1999 "Update on Scleroderma, " Internal Medicine Resident Lecture, FMLH/VAMC |
01/03/2001 NSAIDS, " Ortho-Rheum Conference |
04/2001 "Management of Fibromyalgia, " Internal Medicine Resident Lecture, FMLH/VAMC |
09/2001 "Fibromyalgia, " Neurology Training Program - Clinical Lecture Series, Medical College of Wisconsin |
12/2001 Scleroderma, " Internal Medicine Resident Lecture, FMLH/MCW |
01/2002 "Osteoporosis, " Ortho-Rheum Conference, Children's Hospital |
04/2004 "Osteoporosis, " Ortho-Rheum Conference, Children's Hospital |
05/2005 Scleroderma, " Internal Medicine Resident Lecture, FMLH/MCW |
08/2005 "Osteoporosis, " Ortho-Rheum Conference, Children's Hospital |
11/02/2006 “Rheumatologic Disease and the Paranasal sinuses and related structures” PGY 1, Core Curriculum for ENT residents |
02/21/2007 "Overview of Pathogenesis and Treatment of Rheumatoid Arthritis, " MCW- PM&R Core Curriculum, FMLH |
03/07/2007 Overview of Pathogenesis and Treatment of Rheumatoid Arthritis Core Curriculum Hand Surgery |
04/20/2007 "Soft Tissue Rheumatism, " Internal Medicine Resident conference, |
05/07/2007 "Soft Tissue Rheumatism, " Internal Medicine Resident conference, |
05/30/2007 "Osteoporosis-Basic Science, " Core Curriculum for Orthopedic Residents, Children's Hospital of WI |
07/18/2007 Rheumatoid Arthritis, Academic Half Day: PGY 2+ |
07/25/2007 Rheumatoid Arthritis, Academic Half Day: PGY 1 |
09/21/2007 Treatment of Psoriatic Arthritis, Dermatology Resident Core Curriculum |
04/09/2008 Overview of Pathogenesis and Treatment of Rheumatoid Arthritis Core Curriculum Hand Surgery |
07/23/2008 Rheumatoid Arthritis, Academic Half Day: PGY 1 |
07/30/2008 Scleroderma, Academic Half Day: PGY 2+ |
09/04/2008 “Rheumatologic Disease and the Paranasal sinuses and related structures” PGY 1, Core Curriculum for ENT residents |
07/08/2009 “Rheumatologic Disease and the Paranasal sinuses and related structures” PGY 1, Core Curriculum for ENT residents |
07/08/2009 ANCA related Vasculitis. PGY 2+ |
08/05/2009 Osteoporosis, Academic Half Day: PGY 1 |
02/17/2010 Overview of Pathogenesis and Treatment of Rheumatoid Arthritis Core Curriculum Hand Surgery |
07/14/2010 Scleroderma, Academic Half Day: PGY 2+ |
09/30/2010 “Rheumatologic Disease and the Paranasal sinuses and related structures” PGY 1, Core Curriculum for ENT residents |
07/21/2013 RA diagnosis and Treatment, PG-1 Academic Half Day |
07/21/2013 Soft Tissue Rheumatism, Fibromyalgia, Academic Half Day |
07/24/2013 Scleroderma: PG2-3 Academic Half Day |
07/29/2015 Scleroderma: PG-1 Academic Half Day |
Continuing Medical Education |
02/1994 "Geriatric Rheumatology", Wisconsin Board Review Course and |
03/1996 "Geriatric Rheumatology, " Wisconsin Board Review Course and |
03/1996 "Fibromyalgia, " Medical Grand Rounds, St. Mary's Hospital, |
05/01/1996 "Management of Fibromyalgia, " MCW Primary Care Update, Traverse City, MI |
02/1997 Osteoporosis Management, " PM&R Grand Rounds, |
04/1998 "Temporal Arthritis, " Medicine Grand Rounds, Medical |
03/1999 "Rheumatoid Arthritis, " Medical Grand Rounds, Kenosha Hospital |
03/1999 "Cox-2 Specific Inhibitors, " Medical Grand Rounds, St. |
04/1999 "New Treatments of Rheumatoid Arthritis, " Medical Grand Rounds, Munson Medical Center, Traverse City, MI |
07/1999 "Scleroderma and Acute Renal Disease, " Medical Grand Rounds, Medical College of Wisconsin, Milwaukee College of Wisconsin |
10/1999 "New Directions in the Management of Arthritis Pain, " |
12/1999 "Cox-2 Specific Inhibitors: A New Era in Arthritis Treatment, " CME Dinner Meeting, Cincinnati, OH |
02/2000 "Treatment of Steroid Induced Osteoporosis, " CME dinner meeting, Milwaukee, WI |
09/2000 "Geriatric Rheumatology, " Wisconsin Board Review Course and |
03/2001 "Osteoporosis: Evaluation and Treatment, " DO Annual Dinner, Milwaukee, WI |
09/2002 "Geriatric Rheumatology, " Wisconsin Board Review Course and |
09/2002 "Fibromyalgia, " Columbia-St. Mary's Fall Clinic, Milwaukee, WI |
10/2002 "New Developments in the Diagnosis and Treatment of Osteoporosis, " Grand Rounds, St. Elizabeth Hospital, Appleton, WI |
11/2003 "Current Recommendations in the Prevention and Treatment of |
05/2004 "Osteoporosis: An Overview of Diagnosis, Prevention and Treatment, " All Saints Healthcare Grand Rounds, St. Mary's Medical Center, Racine, WI |
10/2004 "Geriatric Rheumatology, " Wisconsin Board Review Course in Geriatric Medicine, Lake Geneva, WI |
05/2006 "Osteoporosis, " Presented by invitation of Dean Dunn at the MCW Alumni Clinic Day, Milwaukee, WI |
09/2006 "Geriatric Rheumatology, " Wisconsin Review Board Review Course in Geriatric Medicine, Waukesha, WI |
12/2006 "Overview of Systemic Sclerosis and the SCOT Tria, " Medical Grand Rounds, St. John's Hospital, University of Oklahoma, Tulsa, OK |
04/09/2008 "Osteoporosis-What's New, Management of Pain, " Co-presented with Dr. Sean Tutton, Intervention Radiologist, Grand Rounds Columbia Hospital, Milwaukee, WI |
04/22/2008 "Osteoporosis-What's New, Management of Pain, " Co presented with Dr. Sean Tutton, Intervention Radiologist, Grand Rounds Columbia Hospital, Milwaukee, WI |
05/01/2008 "Scleroderma- Advances in Treatment and Etiology, " NE Rheumatology, Appleton, WI |
09/25/2008 "Geriatric Rheumatology, " Wisconsin Board Review Course in Geriatric Medicine, The Abbey, Fontina, WI |
03/26/2010 "Systemic Scleroderma, A complex disease affecting real people, " Grand Rounds, Dept of Medicine, Helfaer Auditorium, FMLH - Milwaukee, WI |
09/10/2013 Rheumatic Disease, Wisconsin Board Review Course in Geriatric Medicine, Grand Geneva, Lake Geneva WI |
Community/Lay Public |
02/1981 Health and Safety Issues for Hospital and Health Workers,” Women's Work, Women's Health: Moderator, A conference on health and safety for Woman. Milwaukee, WI |
02/1984 “Medical Emergencies Common Illnesses and Injuries,” Participated as group leader in Health Activation Series at MCMC,
Milwaukee, WI
|
03/1987 “Medical Aspects of Substance Abuse,” AFSME District Council 48 Conference, Milwaukee, WI |
1987 - 1995 Medical Volunteer, St. Francis Meal Program Clinic, Milwaukee, WI |
09/1989 “Rheumatologic Conditions Affecting Productivity,” Moderator Central State Occupational Medical Association Fall Seminar, Milwaukee, WI |
04/1992 “Overview of Rheumatology, Medication, Treatments, Etc.,” Wisconsin Association of Life and Health Underwriters, Milwaukee, WI |
07/1992 “Therapy and Treatment of Arthritis,” Minority Premedical Apprenticeship Program Medical College of Wisconsin, Milwaukee, WI |
06/1993 “Overview of Arthritis,” Medical Social Services, Milwaukee County Hospital, Milwaukee, WI |
11/1995 “Overview of Lupus,” Lupus Society of Wisconsin, Milwaukee, WI |
1995 - 2007 Member, ESYCM Interparish Commission, Milwaukee, WI |
02/1997 “Osteoporosis,” Federation of Nurse Retirees, Local 5001, Milwaukee, WI |
11/1997 “Osteoporosis,” Community Education Froedtert Hospital, Milwaukee, WI |
06/1999 “Benefits and Limitations of Current Therapies for Treatment of Osteoarthritis,” Patient Education Lecture, Oshkosh, WI |
05/2001 “Osteoporosis: Healthy Aging Series,” Waukesha Area Technical College, Waukesha, WI |
10/2002 “New Developments in Treatments of Osteoporosis,” Patient Education Lecture, Park Plaza Valley Inn, Neenah, WI |
04/01/2004 “Bone Health,” Community Education Lecture sponsored by Froedtert and Medical College, Milwaukee, WI |
10/08/2005 “Scleroderma and PAH: An Educational Update; Shedding Light on Pulmonary Arterial Hypertension,” Scleroderma Foundation Support Group sponsored by the Pulmonary, Hypertension Association, Holiday Inn Chicago City Center, Chicago Lupus Foundation, Milwaukee Chapter, IL |
10/08/2005 “Osteoporosis and the Lupus Patient,” Lupus Foundation Milwaukee Chapter, Helfaer Auditorium, FMLH, Milwaukee, WI |
09/30/2009 “Osteoporosis Update and Treatment of Bone Pain,” Community
Education Lecture sponsored by Froedtert and Medical College, presented with Dr. Sean Tutton, Community Center, FMLH, Milwaukee, WI
|
EXTRAMURAL TEACHING: |
Medical Student Education |
1982 - Present Medical College of Wisconsin
Affiliated Hospitals, Medical Ward Staffing |
1987 - Present Froedtert and Medical College Rheumatology Clinic, Staff |
2000 - Present Froedtert and Medical College Osteoporosis Clinic, Staff |
Resident and Fellow Education |
1980 - 1982 Milwaukee County Medical Complex, General Medicine Staff for Residents, General Internal Medicine
Clinic |
1982 - 1988 General Internal Medicine
Clinic, Milwaukee County Medical Complex, General Medicine Staff for Residents |
07/1992 St. Michael's Hospital, Milwaukee, WI, NSAID's-Indications/Complications,amily Practice Resident Lecture |
03/1993 Milwaukee County Medical Complex, "Rheumatoid Arthritis” Internal Medicine Resident Lecture |
04/1993 Milwaukee County Medical Complex, “Spondyloarthropathies,” Internal Medicine Resident Lecture |
02/1994 Medical College of Wisconsin Pain Clinic, FMLH, “Fibromyalgia” |
Continuing Medical Education |
1995 Woods VA Hospital, Update on Inflammatory Myopathies,” Medical Grand Rounds |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Sullivan D, Csuka ME, Blanchard B. Erythromycin ethylsuccinate hepatotoxicity. JAMA. 1980 Mar 14;243(10):1074. |
2. Csuka, M: McCarty, DJ. A Simple Measurement of Lower Extremity Muscle Strength. American Journal of Medicine 78:77-81, 1985 Jan;78(1):77-81 PMID: 3966492 01/01/1985. |
3. Hansen, RM; Csuka, ME; McCarty, DJ. Gold Induced Aplastic Anemia. A Complete Response to Corticosteroids, Plasmapheresis and N-Acetylcysteine Infusion. The Journal of Rheumatology 1985 Aug; 12(4):794-7 PMID: 4057204 08/01/1985. |
4. Csuka, M; Carrera, GF; McCarty, DJ. Treatment of Intractable Rheumatoid Arthritis with Combined Cyclophosphamide, Azathioprine, and Hydroxychloroquine: A Follow-Up Study. JAMA 1986 May 02;255(17):2315-9 PMID 3959321 05/02/1986 |
5. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine: A Follow-Up Study. Csuka M; Carrera GF; McCarty DJ. JAMA 1986 May 02;255(17):2315-9 PMID 3959321 05/02/1986. |
6. Csuka, M; Brewer, B; Lynch, KL; McCarty, DJ. Osteonecrosis, Fractures, and Protrusion Acetabula Secondary to X-irradiation Therapy for Prostatic Carcinoma. The Journal of Rheumatology 1987 Feb;14(1):165-70 PMID: 3106631 02/01/1987. |
7. McHugh, NJ; Csuka, M; Watson, H; Belcher, G; Amadi, A; Ring, EFJ; Black, CM; Maddison, PJ. Infusion of Iloprost, a Prostacyclin Analogue for Treatment of Raynaud's Phenomenon in Systemic Sclerosis. Ann Rheum Dis 1988 Jan;47(1):43-7 PMID: 2449871 01/01/1988. |
8. Csuka, ME, McCarty, DJ. Aspirin and the treatment of rheumatoid arthritis. Rheumatic Diseases Clinic of North American 1989 Aug;15(3):439-54 PMID: 2672131 08/01/1989. |
9. May, GD; Black, CM; Olsen, NJ; Csuka, ME, Tanner, BS; Belling, L; Porter, JA; Wilkinson, GR; Branch, RA. Scleroderma is Associated with Difference in Individual Routes of Drug Metabolism: A Study with Dapsone, Debrisoquine and Mephenytoin. Clin Pharm and Therapeutics 1990 Sep;48(3):286-95 PMID: 2401127 09/01/1990. |
10. Derfus, BA; Csuka, ME; Carrera, GF; Hanson, GA; Smith, RE. Bone Remodeling After Growth Factor and Cyclosporine A Therapy for Aplastic Anemia. The Journal of Rheumatology 1991 May;18(5):738-42 PMID: 1865422 05/01/1991. |
11. Black, C; May, G; Csuka, ME; Lupoli, S; Wilkinson, GR; Branch, RA. Activity of Oxidative Routes of Metabolism of Debrisoquine, Mephenytoin and Dapsone is Unrelated to Pathogenesis of Vinyl Chloride-induced Disease. Clinical Pharmacol Ther 1992 Dec;52(6):659-67 PMID: 1458774 12/01/1992. |
12. McCarty, DJ; Csuka, ME; McCarthy, G; Trotter, D. Treatment of Pain Due to Fibromyalgia With Topical Capsaicin: A Pilot Study. Seminars in Arthritis and Rheumatism 23:41-47, 1994. |
13. Taylor, ML; Trotter, DR; Csuka, ME. The Prevalence of Physical-Sexual Abuse in Women Diagnosed with Primary Fibromyalgia. Arthritis Rheum 1995 Feb;38(2):229-34 PMID: 7848313 02/01/1995. |
14. Csuka, ME; Hanson, GA. Resolution of Soft Tissue Sarcoma in a Patient with Rheumatoid Arthritis after Discontinuation of Azathioprine. Archives of Internal Medicine 1996 Jul 22;156(14):1573-6 PMID: 8687266 07/22/1996. |
15. Lorenzo, JP; Csuka, ME; Derfus, BA; Gotoff, RA; McCarthy, GM. Concurrent Gout and Mycobacterium Tuberculosis Arthritis. The Journal of Rheumatol 1997 Jan;24(1): 184-6 PMID: 9002033 01/01/1997. |
16. Wigley, FM; Korn, JH; Csuka, ME; Medsger, TA, Jr; Rothfield, NF; Ellman, M; Martin, R, Collier; DH, Weinstein, A; Furst, DE; Jimenez, SA; Mayes, MD; Merkel, PA; Gruber, B; Kaufman, L; Varga, J; Bell, P; Kern, J; Marrott, P; White, B; Simms, RW; Phillips, AC; Seibold, JR. Oral Iloprost Treatment in Patients with Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-Controlled, Double-Blind Study. Arthris Rheum 1998 Apr;41(4):670-7 PMID: 9550476 04/29/1998. |
17. Seibold, JR; Korn, JH; Simms, R; Clements, PJ; Moreland, LW; Mayes, MD; Furst, DE; Rothfield, N; Steen, V; Weisman, M; Collier, D; Wigley, FM; Merkel, PA; Csuka, ME; Hsu, V; Rocco, S; Erikson, M; Hannigan, J; Harkonen, WS; Sanders, ME. Recombinant Human Relaxin in the Treatment of Scleroderma: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Intern Med 2000 Jun 06;132(11):871-9 PMID: 10836913 06/03/2000. |
18. Merkel, PA; Herlyn, K; Martin, RW; Anderson, JJ; Mayes, MD; Bell, P; Korn, JH; Simms, RW; Csuka, ME; Medsger, TA, Jr; Rothfield, NF; Ellman, MH; Collier, DH; Weinstein, A; Furst, DE; Jimenez, SA; White, B; Seibold, JR; Wigley, FM. Measuring Disease Activity and Functional Status in Patients with Scleroderma and Raynaud's Phenomenon. Arthritis Rheum 2002 Sep;46(9):2410-20 PMID: 12355489 10/02/2002. |
19. Prajapati, DN; Knox, JF; Emmons, J; Saeian, K; Csuka, ME; Binion, DG. Leflunomide Treatment of Crohn's Disease Patients Intolerant to Standard Immunomodulator Therapy. J Clin Gastroenterol 2003 Aug;36(2):125-8 PMID: 12869881 Scopus ID: 2-s2.0-0038115119 07/19/2003. |
20. Mayes, MD; O'Donnell, D; Rothfield, NF; Csuka, ME. Minocycline Is Not Effective in Systemic Sclerosis: results of an open-label multicenter trial. Arthritis Rheum 2004 Feb;50(2):553-7 PMID: 14872498 02/12/2004. |
21. Jaovisidha, K; Csuka, ME; Almagro, U; Soergel, K. Severe Gastrointestinal Involvement In Systemic Sclerosis: Report of five cases and review of the literature. Semin Arthritis Rheum 2005 Feb;34(4):689-702 PMID: 15692963 02/05/2005. |
22. Weihrauch, D; Xu, H; Shi, Y; Wang, J; Brien, J; Jones, DW; Kaul, S; Komorowski, RA; Csuka, ME; Oldham, KT; Pritchard, Jr, KA. Effects of D-4F vasodilation, oxidative stress, angiostatin, myocardial inflammation and angiogenic potential in Tight-skin mice. Am J Physiol Heart Circ Physiol 2007 Sep;293(3):H1432-41 PMID: 17496220 Scopus ID: 2-s2.0-34548433520 05/15/2007. |
23. Gazi, H; Pope, JE; Clements, P; Medsger, TA; Martin, RW; Merkel, PA; Kahaleh, B; Wollheim, FA; Baron, M; Csuka, ME; Emery, P; Belch, JF; Hayat, S; Lally, EV; Korn, JH; Czirjak, L; Herrick, A;Voskuyl, AE; Bruehlmann, P; Inanc, M; Furst, DE; Black, C; Ellamn, MH; Moreland, L; Rothfield, NF; Myes, M; Mckown, KM; Kreig, T; Siebold, JR. Outcome measurements in scleroderma: results from a delphi exercise. Journal of Rheumatology 2007 Mar;34(3):501-9 PMID: 17299843 02/15/2007. |
24. Khanna, D; Clements, PJ; Furst, DE; Korn, JH; Ellman, M; Rothfield, N; Wigley, FM; Moreland, LW; Silver, R; Kim, YH; Steen, VD; Firestein, GS; Kavanaugh, AF; Weisman, M; Mayes, MD; Collier, D; Csuka, ME; Simms, R; Merkel, PA; Medsger, TA Jr; Sanders, ME; Maranian, P; Seibold, Jr. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism 60(4):1102-11, 2009. |
25. Chung, L; Shapiro, L; Fiorentino, D; Baron, M; Shanahan, J; Sule, S; Hsu, V; Rothfield, N; Steen, V; Martin, RW; Smith, E; Mayes, M; Simms, R; Pope, J; Kahaleh, B; Csuka, ME; Gruber, B; Collier, D; Sweiss, N; Gilbert, A; Dechow,FJ; Gregory, J; Wigley, FM. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. Arthritis Rheum 2009 Mar;50(3):870-7 PMID: 19248104 02/28/2009. |
26. Khanna, D; Clements, PJ; Furst, DE; Korn, JH; Ellman, M; Rothfield, N; Wigley, FM; Moreland, LW; Silver, R; Kim, YH; Steen, VD; Firestein, GS; Kavanaugh, AF; Weisman, M; Mayes, MD; Collier, D; Csuka, ME; Simms, R; Merkel, PA; Medsger, TA Jr; Sanders, ME; Maranian, P; Seibold, JR. Relaxin Investigators and the Scleroderma Clinical Trials Consortium. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2009 Apr;60(4):1102-11 PMID: 19333948 PMICID: PMC3711466 04/01/2009. |
27. Xu, H; Zaidi, M; Struve, J; Jones, DW; Krolikowski, JG; Nandedkar, S; Lohr, NL; Gadicherla, A; Pagel, PS; Csuka, ME; Prichard, KA; Weihrauch, D. Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis. American Journal of Physiology-Cell Physiology 2011 Mar;300(3):C550-6 PMID: 21160034 PMCID: PMC3063974 Scopus ID: 2-s2.0-79952158516 12/17/2010. |
28. Kushi, J; Csuka, ME. Generalized Morphea after Breast Cancer Radiation Therapy. Case Rep Rheumatol 2011;2011:951948 PMID: 22937449 PMC3420376 01/01/2011. |
29. Fransen, J Johnson SR, van den Hoogen, F Baron, M Allanore, Y Carreira, PE Czirjak, L Denton, CP Distler, O Furst, DE Gabrielli, A Inanc, M Kahaleh, B Kowal-Bielecka, O Medsger, TA Mueller-Ladner, U Riemekasten, G Sierakowski, S Valentini, G Veale, D Vonk, MC Walker, U Chung, L Clements, PJ Collier, DH Csuka, ME Jimenez, S Merkel, PA Seibold, JR Silver, R Steen V, Tyndall, A Matucci-Cerinic, M Pope, JE Khanna, D Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken) 2012 Mar;64(3):351-7 PMID: 22052558 PMCID: PMC3288452 11/05/2011. |
30. Bae, S Saggar, R Bolster, MB Chung, L Csuka, ME Derk, C Domsic, R Fischer, A Frech, T Goldberg, A Hinchcliff, M Hsu, V Hummers, L Schiopu, E Mayes, MD McLaughlin, V Molitor, J Naz, N Furst, DE Maranian, P Steen, V Khanna, D. Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Ann Rheum Did 2012 Aug;71(8):1335-42 PMID: 22307943 PMCID: PMC3398226 02/07/2012. |
31. Hung, EW Mayes, MD Sharif, R Assassi, S Machicao VI Hosing, C St. Clair, EW Furst DE, Khanna, D Forman, S Mineishi, S Phillips, K Seibold, JR Bredeson, C Csuka, ME |
32. Nash, RA Wener, MH Simms, R Ballen, K , Storek, J Goldmuntz, E Welch, B Keyes-Elstein, L Castina, S Crofford, LJ Mcsweeney, P Sullivan, KM. Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial. Journal of Rheumatology 2013 Apr;40(4):455-60 PMID: 23418384 PMCID: PMC3652008 02/19/2013. |
33. Ryan, P Maierle, D, Csuka, ME Thomson, A Szabo. Computer-based intervention to enhance self-management of calcium and vitamin D intake in women. West J Nurs Res 2013 Sep;35(8):986-1010 PMID: 23539320 PMCID: PMC4545626 03/30/2013. |
34. Van den Hoogen, F Khanna, D, Fransen, J Johnson, SR Braon, M Tyndall, A Matucci-Cerinic, M Naden, RP Mdsger, TA Carreira, PE Riemekasten, G Clements, PJ Denton, CP Distler, O Allanor, Y Furst, DE Gavrielle, A Mayer, MD van Laar, JM Seibold JR Czirjak, L Steen, VD Inanc, M Kowal-Bielecka, O Mulle-Ladner, U Valentini, G Veale, DJ Vonk, MC Walker, UA Chung, L Collier DH Csuka, ME Fessler, BJ Guiducci, S Herrick, A Hsu, VM Jimenez, S Kahaleh, B Merkel, PA Sierakowski, S Silver, RM Simms, RW Varga, J Pope, JE. 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013 Nov;65(11):2737-47 PMID: 24122180 PMCID: PMC3930146 10/15/2013. |
35. Chung, L Domsic, RT Lingala, B Alkassab, F Bolster, M Csuka, ME Derk, C Fischer, A Frech, T Furst, DE Gomberg-Maitland, M Hinchcliff, M Hsu, V Hummers, LK Khanna, D Medsger, TA Molitor, JA Preston IR, Schiopu, E Shapiro, L Silver, R Simms, R Varga, J Gordon, JK Steen, VD. Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Car Res (Hoboken) 2014 Mar;66(3):489-95 PMID: 23983198 08/29/2013. |
36. Hsu VM. Chung L. Hummers LK. Wigley F. Simms R. Bolster M. Silver R. Fischer A. Hinchcliff ME. Varga J. Goldberg AZ. Derk CT. Schiopu E. Khanna D. Shapiro LS. Domsic RT. Medsger T. Mayes MD. Furst D. Csuka ME. Molitor JA. Alkassab F. Steen VD. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. Semin Arthritis Rheum 2014 Aug;44(1):55-62 PMID: 24709277 04/09/2014. |
37. Fischer A, Swigris JJ, Bolster MB, Chung L, Csuka ME, Domsic R, Frech T, Hinchcliff M, Hsu V, Hummers LK, Gomberg-Maitland M, Mathai SC, Simms R, Steen VD. Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters. Clin Exp Rheumatol 2014 Nov-Dec;32(6 Suppl 86):S-109-14 PMID: 25372796 11/06/2014. |
38. Shah AA, Schiopu E, Chatterjee S, Csuka ME, Frech T, Goldberg A, Spiera R, Peng SL, McBride RJ, Cleveland JM, Steen V. The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil. J Rheumatol. 2016 Sep;43(9):1665-71. |
39. Sullivan KM; Goldmuntz EA; Keyes-Elstein L; McSweeney PA; Pinckney A; Welch B; Mayes MD; Nash RA; Crofford LJ; Eggleston B; Castina S; Griffith LM; Goldstein JS; Wallace D; Craciunescu O; Khanna D; Folz RJ; Goldin J; St Clair EW; Seibold JR; Phillips K; Mineishi S; Simms RW; Ballen K; Wener MH; George GE; Heimfeld S; Brasington R; Csuka ME; Bredeson C; Keever-Taylor C; Domsic RT; Kahaleh MB; Medsger T; Furst; SCOT Study Investigators. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. N Engl J Med 2018 01 04;378(1):35-47 PMID: 29298160 PMCID: PMC5846574 01/04/2018. |
40. Ryan P, Papanek P, Csuka ME, Brown ME, Hopkins S, Lynch S, Scheer V, Schlidt A, Yan K, Simpson P, Hoffman R, Striving to be Strong Team) Background and method of the Striving to be Strong study a RCT testing the efficacy of a m-health self-management intervention. Contemp Clin Trials 2018 08;71:80-87 PMID: 29894865 Scopus ID: 2-s2.0-85048278984 06/13/2018. |
41. Hsu VM, Chung L, Hummers LK, Shah A, Simms R, Bolster M, Hant FN, Silver RM, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domsic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Saketkoo LA, Salazar CR, Steen VD. Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry. J Rheumatol. 2019 Feb;46(2):176-183. |
42. Cleland BT, Papanek P, Ingraham BA, Harkins A, Garnier-Villarreal M, Woo D, Csuka ME, V Ng A. Determinants of low bone mineral density in people with multiple sclerosis: Role of physical activity. Mult Scler Relat Disord. 2020 Feb;38:101864. |
43. Ryan P, Brown RL, Csuka ME, Papanek P. Efficacy of Osteoporosis Prevention Smartphone App. Nurs Res. 2020;69(1):31-41. PMCID: PMC7105101 |
44. Francesca Ingegnoli 1, Ariane L Herrick 2, Tommaso Schioppo 1, Francesca Bartoli 1, Nicola Ughi 1, John D Pauling 3, Alberto Sulli 4, Maurizio Cutolo 4, Vanessa Smith 5 6 7, European League against Rheumatism (EULAR) study group on microcirculation in rheumatic diseases and the Scleroderma Clinical Trials Consortium Collaborators, European League against Rheumatism (EULAR) study group on microcirculation in rheumatic diseases and the Scleroderma Clinical Trials Consortium: Mary Ellen Csuka, et. al. Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus. Rheumatology (Oxford) 2021 Mar 2;60(3):1410-1418 doi: 10.1093/rheumatology/keaa457. |
45. Lymphocyte subset abnormalities in early severe scleroderma favor a Th2phenotype and are not altered by a prior immunosuppressive therapy. Shah A, Storek J, Woolson r, Pinckney A, Keyes-Elstein L, Wallace PK, Sempowski GD, McSweeney P, Mayes MD, Crofford L, Csuka ME, Phillips K, Khanna D, Simms R, Ballen K, LeClerq S, St Clair W, Nixon AB, Nash R, Wener M, Brasington R, Silver R, Griffith LM, Furst DE, Goldmuntz E, Sullivan KM. Rheumatology (Oxford). 2022 Feb 2:keac015. doi: 10.1093/rheumatology/keac015. Online ahead of print. PMID: 35108379 |
46. Zheng B, Wang M, McKenna K, Shapiro L, Silver R, Csuka ME, van den Hoogen F, Robinson D, Pauling JD, Hummers L, Krieg T, Del Galdo F, Spiera R, Jones N, Khalidi N, Vacca A, de Vries-Bouwstra JK, Gordon J, Baron M. Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis. Arthritis care & research. 74(11):1806-1812, 2022 11.
UI: 38662853
|
47. Keyes-Elstein L, Pinckney A, Goldmuntz E, Welch B, Franks JM, Martyanov V, Wood TA, Crofford L, Mayes M, McSweeney P, Nash R, Georges G, Csuka ME, Simms R, Furst D, Khanna D, Clair EWS, Whitfield ML, Sullivan KM. Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data. Arthritis Care Res (Hoboken). 2023 Feb;75(2):307-316. doi: 10.1002/acr.24785. Epub 2022 Nov 16. PMID: 34533286; PMCID: PMC8926930. |
48. Collaborators RESOLVE-1 Study Group: Arthur Kavanaugh, Daniel E Furst, Suzanne Kafaja, Lorinda Chung, Aryeh Fischer, Virginia Steen, John Varga, Lesley Saketkoo, Laura Hummers, Flavia V Castelino, Robert Simms, Vivek Nagaraja, Jerry Molitor, Nicole M Orzechowski, Vivien M Hsu, Elana J Bernstein, Robert Spiera, Jessica Gordon, Soumya Chatterjee, Bashar Kahaleh, Nora Sandorfi, Robyn T Domsic, Edwin Smith, Zoran Kurepa, Maureen Mayes, Tracy Frech, Mary Ellen Csuka, Susanna Proudman, Vivek Thakkar, Wendy Stevens, Peter Youssef, Murray Baron, David Robinson, Claudia Kedor, Jörg Distler, Stephanie Finzel, Pia Moinzadeh, Ramona König, Christiane Pfeiffer, Norbert Blank, Alexandra Balbir-Gurman, Itzhak Rosner, Yair Levy, Merav Lidar, Eun Bong Lee, Chang Keun Lee, Jae-Bum Jun, Ji Hyeon Ju, V A S H Dalm, Anne A Schouffoer, Jeska Kirsten de Vries-Bouwstra, Dorota Krasowska, Piotr Leszczynsk, Bozena Kowalewska, Ivan Castellvi Barranco, Juan Jose Alegre Sancho, Andrea Rubbert-Roth, Oliver Distler, Francesco Del Galdo, Christopher C Denton, David D'Cruz, Ariane Herrick, Colin Baines, Bridget Griffiths, Karen Douglas Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis Arthritis Rheumatol 2023 Sep;75(9):1608-1618. Doi: 10.1002/art.42510.Epub 2023 June 15. |
49. Rosenthal AK, Csuka ME, Halverson P. Daniel J McCarty, MD: A Giant of Rheumatology. Rheum Dis Clin North Am. 2024 Feb;50(1):15-23. |
50. Shah A, Storek J, Woolson R, Pinckney A, Keyes-Elstein L, Wallace PK, Sempowski GD, McSweeney P, Mayes MD, Crofford L, Csuka ME, Phillips K, Khanna D, Simms R, Ballen K, LeClercq S, Clair WS, Nixon AB, Nash R, Wener M, Brasington R, Silver R, Griffith LM, Furst DE, Goldmuntz E, Sullivan KM. Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy. Rheumatology (Oxford). 2022 Oct 06;61(10):4155-4162. PMCID: PMC9536786 |
51. Keyes-Elstein L, Pinckney A, Goldmuntz E, Welch B, Franks JM, Martyanov V, Wood TA, Crofford L, Mayes M, McSweeney P, Nash R, Georges G, Csuka ME, Simms R, Furst D, Khanna D, Clair EWS, Whitfield ML, Sullivan KM. Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data. Arthritis Care Res (Hoboken). 2023 Feb;75(2):307-316. PMCID: PMC8926930 |
Books, Chapters, and Reviews |
1. Csuka, ME; Goodwin, JS. Rheumatoid Arthritis. In Principles of Geriatric Medicine and Gerontology, 2nd Ed., pg. 869-879. Hazzard WR, Andres RB, Bierman EL, Blass JP (eds). New York: McGraw-Hill, 1988. |
2. Csuka, ME; McCarty, DJ. Aspirin and the Treatment of Rheumatoid Arthritis. Clinic of Rheumatic Disease 15: 439-454; 1989. |
3. Krasnow, AZ; Collier, BD; Csuka, ME; Hellman, RS; Isitman, AT. Nuclear Medicine Evaluation of Amyloidosis. Nuclear Medicine Annual; pp. 123-156; 1992. |
4. Csuka, ME. Disabling Rheumatologic Conditions Affecting Women. In Welner's Guide to the Care of Women with Disabilities, pg. 48-68. Welner SL, Haseltine, F (eds). New York: Lippincott, Williams & Wilkins 2004. |
5. Daniel J McCarty, MD: A Giant of Rheumatology. Rheum Dis Clin North Am 2024 Feb;50(1):15-23 PubMed ID 37973282 Scopus ID 2-s2.0-085169505673 |
Editorials, Letters To Editor, Other |
1. Csuka, ME; McCarty, DJ. Transient Hypothermia after Corticosteroid Treatment of Subacute Cutaneous Lupus Erythematosus. J Rheumatol 1984 Feb;11(1):112-3 PMID: 6699827 02/01/1984. |
2. McCarty, D; Csuka, ME. Aspirin in the Treatment of Chronic Inflammatory Arthritis. JAMA 1987 Mar 13;257(10):1331 PMID: 3820440 03/13/1987. |
3. McCarty, DJ; Csuka, ME. Polysynovitis associated with acute Epstein-Barr virus infection. J Rheumatol 1998 Oct;25(10):2039-40 PMID: 9779871 10/21/1998. |
Non-Refereed Journal Publications/Original Papers |
1. Gambert, SR; Csuka, ME; Duthie, EH Jr; Tiegs, R. Interpretation of Laboratory Tests in the Elderly. 1.A Clinician's Guide to hepatorenal function tests. Postgrad Med 1982 Sep;72(3):147-52 PMID: 7122336 Scopus ID: 2-s2.0-0020385067 09/01/1982. |
2. Csuka, ME. High Dose Immununosuppressive Therapy and Autologous Hematopoietic Stem Cell Transplantation for Treatment of Severe Systemic Sclerosis. Scleroderma Care and Research 3:3-13, 2005. |
Abstracts |
1. Csuka, ME; Black, C; May, G; Porter, J; Branch, R. Rapid Dapsone Hydroxylation in Systemic Sclerosis; A Novel Hypothesis. Arthritis and Rheumatism 30:S99, D43, 1987. |
2. Csuka, ME; Valen, PA; Rilling, W; Grist, T; Wortmann, RL. In vivo Assessment of Muscle Energetics in Patients with Primary Fibromyalgia. Arthritis and Rheumatism 32:R33, 1989. |
3. Lupoli, S; Csuka, ME; Shapiro, L; Black, C. Cardiac Disease in Systemic Sclerosis (SSC): Non-Invasive Investigtions during Medicum Term Follow-Up. Arthritis and Rheumatism 32:R33, 1989. |
4. Black, C; Olsen, N; May, G; Csuka, ME; Tanner, B; Wilkinson, GR; Branch, RA. Scleroderma is Associated With Different Effects on Individual Routes of Drug Metabolism: A Study with Dapsone, Debrisoquine, and Mephenytoin. Arthritis and Rheumatism 32:S94, C22, 1989. |
5. Trotter, D; McCarty, DJ; Csuka, ME. Treatment of Dermatomyositis / Polymyositis (DM / PM) with Combination Chemotherapy in Early Disease. Presented at Polymyositis Symposium, San Antonio, Texas, March 21, 1991. |
6. Csuka, ME; Branch, RA; Wilkinson, GR; May, G; Lupoli, S; Black, C. Activity of Oxidative Routes of Metabolism of Debrisoquine, Mephenytoin and Dapsone in Vinylchloride-Induced Disease: A Possible Pathogenic Role for Cytochrome P450IID. Presented at the International Conference on Scleroderma and Scleroderma-Like Diseases, Swieradow-Zdroj, Poland, June 1991. |
7. Darton, K; Tanner, SB; Watson, HR; Csuka, ME; Black, CM. Long-Term Follow-Up of Iloprost Infusion in Patients with Connective Tissue Disease Using Infra-Red Thermography. Presented at Fifth World Congress for Microcirculation, Louisville, Kentucky, September 1991.
|
8. Cardenal, A; Masuda, I; Ono, W; Haas, AL; Ryan, LM; Csuka, ME; Trotter, D; McCarty, DJ. Serum nucleoside triphosphate pyrophosphohydrolase (NTPPHASE) activity: Elevated levels in osteoarthritis, calcium phyrophosphate crystal deposition disease and fibromyalgia. Arthritis & Rheumatism 39:S83 #341, 1996. |
9. Seibold, JR; Korn, J; Simms, R; Clements, PJ; Moreland, L; Mayes, MD; Merkel, DE; Csuka, ME; Rocco, S; Erikson, M; Hannigan, J; Harkonen, WS; Sanders, ME. Controlled Trial of recombinant human relaxin (rhRlxn) in diffuse scleroderma (DS). Arthritis and Rheumatism 40:S123 #557, 1997. |
10. Csuka, ME; Taylor, ML; Tapal, M; Madigan, GJ; Gardner, J; Tonellato, P. Randomized double blind placebo controlled trial comparing melatonin to placebo in the treatment of fibromyalgia. Arthritis & Rheumatism 41:S258 #1356, 1998. |
11. Mayes, MD; O’Donnell, D; Csuka, ME; Rothfield, NF. Multicenter, open-label trial of minocycline in early diffuse SSc. Arthritis & Rheumatism 46:S357 #914, 2002.
|
12. Chung, L, Baron; M, Collier, D; Csuka, ME; Fiorentino, D; Gruber, B; Hsu, V; Kahaleh, B; Martin, R; Mayes, M; Pope, J; Rothfield, N; Shanahan, J; Shapiro, L; Simms, R; Smith, E; Steen, V; Sule, S; Sweiss, N; Matthews, E; Gilbert, A; Dechow, J; Wigley, F. A multi-center, blinded, randomized, placebo-controlled, “in-life” study of MQX-503, a topical gel formulation of nitroglycerin, in subject with Raynaud’s phenomenon. 2007 |
13. Schiopu, E; Hsu ,VM; Hummers, LK; Shapiro, LS; Mayes, MD; Csuka, ME; Derk, CT; Chung, LS; Varga, J; Furst, DE; Silver, RM; Wigley, FM; Seibold, JR; Steen, VD. Pulmonary Hypertension (PH)-Assessment and Recognition of Outcomes in Scleroderma (Systemic Sclerosis, SSc): PHAROS. Arthritis & Rheumatism 56:S489 #1208, 2007. |
14. Fischer, A; Impens, A; Hsu, V; Shapiro, L; Mayes, M; Hummers, L; Csuka, ME; Chun, L; Hinchcliff, M; Varga, J; Derk, C;Seibold, J; Steen. “PHAROS” Pulmonary Hypertension (PH) Assessment and Recognition of Outcomes in Systemic Sclerosis (SSc): Pre-Pulmonary Arterial Hypertension (PAH) Preliminary Outcomes. Arthritis & Rheumatism 58:S377 #566, 2008. |
15. Mayes, MD; Keyes-Elstein, L; Crofford LJ; Csuka, ME; Furst, DE; Goldmuntz, E; McSweeney P; Nash, R; Wallace, D; Sullivan. Gastric Antral Vascular Ectasia (GABE) in Early Diffuse SSc: Report from the SCOT Trial. Arthritis & Rheumatism 58:S378 #571, 2008. |
16. Hsu, V; Shapiro, L; Fiorentino, D; Rothfield, N; Steen, V; Martin, R; Smith, E; Sule, S; Csuka, ME; Mayes, M; Kahaleh, B; Gruber, B; Simms, R; Sweiss, N; Dechow, FJ; Gregory, JK; Wigley, FM. Phase III Open-Label Study of Topical Nitroglycerin, MQX-503, in the Treatment and Prevention of Raynaud’s Phenomenon. Arthritis & Rheumatism 58:S820 #1773, 2008. |
17. Khawari, M; Jacob, S; Soto, FJ; Presberg, K; Csuka, ME. Prevalence of Obstructive Sleep Apnea in Patients with Connective Tissue Disease and Pulmonary Hypertension. Arthritis & Rheumatism 58:S829 #1798, 2008.
|
18. Hinchcliff, ME; Hsu, V; Bolster, M; Hummers, L; Seibold, J; Csuka, ME; Chung, L; Shapiro, L; Derk, C; Fischer, A; Wigley, F; Steen, V. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): Patients with Pulmonary Hypertension. Arthritis & Rheumatism 58: S948 #2124, 2008.
|
19. Fischer, A; Mathai, S; Bolster, MB, Chung, L; Csuka, ME; Domsic, R; Frech, T; Hinchliff, M; Hsu, V; Hummers, L; Kolfenbach, J; Gomberg-Maitland, M; Manu, A; Simms, R; Steen, V. Pulmonary Hypertension and Interstitial Lung Disease within Pharos: Impact of Extent of Fibrosis and Pulmonary Physiology On Cardiac Hemodynamic Parameters. Rheumatology/ILD Program, National Jewish Health, Denver, CO, Medicine, Johns Hopkins University, Baltimore, MD, Medicine, Medical University of South Carolina, Charleston, SC, Rheumatology, Stanford University Medical Center, Palo Alto, CA, Rheumatology, Medical College of Wisconsin, Milwaukee, WI, Medicine, Rheumatology, University of Pittsburgh, Pittsburgh, PA, Internal Medicine Division of Rheumatology, University of Utah School of Medicine, SLC, UT, Division of Rheumatology, Northwestern University Medical School, Chicago, IL, Rheumatology, RWJ Medical School Scleroderma Program, New Brunswick, NJ, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, University of Chicago, Chicago, Rheumatology Georgetown University Medical Center, District of Columbia, Rheumatology, Boston University School of Medicine, Boston, MA, Department of Rheumatology, Georgetown University Medical Center, Washington DC. 2012 ACR/ARHP Annual Meeting.
|
20. Van de Hoogen, F; Khanna, D; Fransen, J; Johnson, SR; Baron, M; Tyndall, A; Matucci-Cerinic, M; Naden, RP; Medsger, TR Jr; Carreira, PE; Riemekasten, G; Clements, PJ; Denton, CP; Distler, O; Allanore, Y; Furst, DE; Gabrielli, A; Mayes, MD; van Laar, JM; Seibold, JR; Czirjak, L; Steen, VD; Inanc, M; Kowal-Bielecka O; Mueller-Ladner, U; Valentini, G; Veale, DJ; Vonk, MC; Walker, UA; Chung, L; Collier, DH; Csuka, ME; Fessler, BJ; Guiducci, S; Herrick, A; Hsu, VM; Jimenez, S; Kahaleh, B; Merkel, PA; Sierakowski, S; Silver, RM; Simms, RW; Varga, J; Pope, JE. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013 Nov;65(11):2737-47. Doi: 10.1002/art.38098. Epub 2013 Oct 3. |
21. Ami A., Shah; Schiopu, E; Chatterjee, S; Csuka, ME; Frech, T; Goldberg, A; Spiera, R; Peng, S; Steen, V. A Retrospective Look at the Recurrence of Digital Ulcers in Patients with Scleroderma after Discontinuation of Oral Treprostinil. Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, Rheumatology, University of Michigan, Ann Arbor, MI, Rheumatic and Immunologic Ds, Cleveland Clinic, Cleveland, OH, Rheumatology, Medical College of Wisconsin, Milwaukee, WI, Division of Rheumatology, University of Utah, Salt Lake City, UT, Division of Rheumatology, North Shore-LIJ Health System, Great Neck, NY, Rheumatology, Hospital for Special Surgery, New York, NY, Benaroya Research Institute/Virginia Mason, Seattle, WA, Department of Rheumatology, Georgetown University Medical Center, Washington, DC. 2014 ACR/ARHP Annual Meeting. |
22. Shah, A; Chatterjee, S; Csuka, ME; Frech, T; Goldberg, A; Spiera, R; Peng, S; Steen, V. A Retrospective Look at the Recurrence of Digital Ulcers in Patients with Scleroderma after Discontinuation of Oral Treprostinil. American College of Rheumatology Annual Conference – Boston Convention and Exhibition Center – presentation number 1927; Nov 17, 2014 |
23. Papanek, Paula; Marquette University; Speltz, Jenna; Csuka, ME; Ryan, Polly. High Prevalence of Low BMD in Middle Aged Healthy Women. Journal of Clinical Densitometry: Assessment & Management of Musculoskeletal Health. Volume 18, 2015 |
24. Shervin, A; Mayes, MD; Pedroza, C; Chang, JT; Furst, DE; Crofford, LJ, Nash, R; McSweeney, P; Csuka, ME; Goldmuntz, E; Keyes-Elstein, L; Wallace, P; Sullivan, K. Immunoablation Followed By Autologous Stem Cell Transplantation in Systemic Sclerosis Patients Decreases Significantly the Interferon Signature. Rheumatology, University of Texas Medical School at Houston, Houston, TX, University of Texas Medical School at Houston, TX, Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, Medicine, Vanderbilt University, Nashville, TN, Colorado Blood Cancer Institute, Denver, CO, Rheumatology, Medical College of Wisconsin, Milwaukee, WI, NIAID, National Institutes of Health, Bethesda, MD, Rho Federal Systems, Inc., Chapel Hill, NC, Roswell Park, Buffalo, NY, Duke University, Durham, NC. 2015 ACR/ARHP Annual Meeting. |
25. Shah AA; Schiopu E; Chatterjee S.; Csuka ME; Frech T; Goldberg A; Spiera R; Peng SL; McBride RJ; Cleveland JM; Steen V. The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil. J Rheumatol 2016 09:43(9):1885-71 PMID: 27307535 06/17/2016.
|
26. Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech T; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TA; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry. Clin Exp Rheumatol 2017 Sep-Oct;35 Suppl 106(4): 106-113 PMID: 27908301 12/03/2016 |
27. Ding, Y; Yeturi, S; Gohr, C; Csuka, ME; Rosenthal, A. Low Nucleoside Triphosphate Pyrophosphohydrolase Activity Contributes to Pathologic Mineralization in Systemic Sclerosis. Medicine, Medical College of Wisconsin, Milwaukee, WI, Medicine, Clement J. Zablocki VA Medical Center, Milwaukee, WI. 2016 ACR/ARHP Annual Meeting. |
28. Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM, SENSCIS Trial Investigators. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. N Engl J Med. 2019 Jun 27;380(26):2518-2528 |
29. American College of Rheumatology (ACR) Convergence November 2023 – San Diego, CA - Chelation Therapy in the Management of Calcinosis Associated with Systemic Sclerosis Alison Fernandes, Ashraf El-Meanawy and ME Csuka, Medical College of Wisconsin, Milwaukee, WI
|